FSRH Clinical Guidance: Progestogen-only Injectable contraception - Updated April 2019

Published on: 30 April 2019

File size: 1103kb PDF

File type: Current Clinical Guidance

Author: FSRH Clinical Effectiveness Unit

This guidance provides evidence-based recommendations and good practice points for health professionals on the use of progestogen-only injectables (depot medroxyprogesterone acetate (DMPA), Depo-Provera) currently available in the UK. It is intended for any health care professional or health service providing contraception or conception advice in the UK.

Your download should start automatically. If not download directly.